NFKB1 and obesity disorder: Subsequently, it was shown that systemic or myeloid cell-specific deletion of IKKβ or upstream molecules of the IKKβ/NFκB pathway, including TLR4, protects mice from the development of obesity-induced insulin resistance [9], [11].